GlassScriptPhysician profile
Saji Koshy
NPI 1982623286
$11,300.87
in general payments reported to CMS, 2019-2025
45 companies · $2,676 in 2025
The $2,676 reported for 2025 was more than what 81% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,172 · 2020: $405 · 2021: $68.91 · 2022: $535 · 2023: $2,551 · 2024: $2,893 · 2025: $2,676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,019 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,018.89 |
| Education | $101.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,722.94 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,095.74 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Sanofi-Aventis U.S. LLC | $1,018.26 | 2019-2025 | |
| Abbvie INC. | $977.01 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $572.68 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Medtronic, INC. | $508.74 | 2022-2025 | Minimed 780g, Endoflip, Inpen Smart Insulin Delivery System |
| Dexcom, INC. | $430.47 | 2019-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $430.28 | 2019-2025 | Freestyle Libre 3, Infinity |
| Corcept Therapeutics | $427.29 | 2019-2025 | Korlym |
| Xeris Pharmaceuticals, INC. | $385.08 | 2023-2025 | Gvoke Hypopen, Recorlev |
| Mannkind Corporation | $313.45 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $313.41 | 2023-2025 | |
| Recordati_rare_diseases_inc. | $288.24 | 2023-2025 | Isturisa, Signifor Lar |
| Beta Bionics, INC. | $257.80 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Ibsa Pharma INC. | $200.60 | 2019-2025 | Tirosint, Tirosint, Licart |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $192.43 | 2020-2025 | Unithroid |
| Astrazeneca Pharmaceuticals LP | $184.09 | 2019-2020 | |
| Medtronic Minimed, INC. | $179.82 | 2019-2020 | |
| Radius Health, INC. | $154.13 | 2019-2025 | Tymlos |
| Cequr Corporation | $142.95 | 2023-2025 | Cequr Simplicity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $141.06 | 2019-2022 | |
| Insulet Corporation | $118.45 | 2019-2024 | Omnipod |
| Tandem Diabetes Care, INC. | $115.84 | 2019-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Janssen Pharmaceuticals, INC | $100.33 | 2019 | |
| Valeritas, INC. | $97.03 | 2019 | |
| Amgen INC. | $95.43 | 2019-2025 | Tepezza, Prolia, Evenity |
| Averitas Pharma INC. | $93.77 | 2024-2025 | Qutenza |
| Nevro Corp. | $91.67 | 2022-2024 | Senza |
| Ascendis Pharma Endocrinology INC | $88.82 | 2025 | Yorvipath |
| Alexion Pharmaceuticals, INC. | $84.22 | 2025 | Strensiq |
| Merck Sharp & Dohme LLC | $73.31 | 2019-2023 | Steglatro, Steglujan, Januvia |
| Kyowa Kirin, INC. | $54.61 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $50.06 | 2019 | |
| Madrigal Pharmaceuticals | $46.11 | 2025 | Rezdiffra |
| Lifescan, INC. | $44.54 | 2023 | |
| Neurocrine Biosciences, INC. | $27.68 | 2024 | Crenessity |
| Amarin Pharma, INC. | $27.17 | 2019 | |
| Tolmar, INC. | $26.70 | 2023-2025 | Jatenzo |
| Kowa Pharmaceuticals America, INC. | $24.31 | 2019-2023 | Livalo |
| Sequel Med Tech, LLC | $22.98 | 2025 | Twiist |
| Ascensia Diabetes Care US INC. | $20.86 | 2023 | |
| Intuity Medical INC | $17.82 | 2022 | |
| Acella Pharmaceuticals, LLC | $16.15 | 2025 | NP Thyroid 60 |
| Verity Pharmaceuticals INC. | $14.92 | 2025 | Tlando |
| Pfizer INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saji Koshy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.